101 related articles for article (PubMed ID: 16904193)
21. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
22. PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.
Kanakasabai S; Walline CC; Chakraborty S; Bright JJ
Brain Res; 2011 Feb; 1376():101-12. PubMed ID: 21192919
[TBL] [Abstract][Full Text] [Related]
23. Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2.
Nicolson K; Freland S; Weir C; Delahunt B; Flavell RA; Bäckström BT
Int Immunol; 2002 Aug; 14(8):849-56. PubMed ID: 12147621
[TBL] [Abstract][Full Text] [Related]
24. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi.
Tadokoro CE; Vallochi AL; Rios LS; Martins GA; Schlesinger D; Mosca T; Kuchroo VK; Rizzo LV; Abrahamsohn IA
J Autoimmun; 2004 Sep; 23(2):103-15. PubMed ID: 15324929
[TBL] [Abstract][Full Text] [Related]
25. AlphaB-crystallin-reactive T cells from knockout mice are not encephalitogenic.
Wang C; Chou YK; Rich CM; Link JM; Afentoulis ME; van Noort JM; Wawrousek EF; Offner H; Vandenbark AA
J Neuroimmunol; 2006 Jul; 176(1-2):51-62. PubMed ID: 16844233
[TBL] [Abstract][Full Text] [Related]
26. IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis.
Weir C; Bernard CC; Bäckström BT
Int Immunol; 2003 Nov; 15(11):1283-9. PubMed ID: 14565926
[TBL] [Abstract][Full Text] [Related]
27. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis.
Suvannavejh GC; Lee HO; Padilla J; Dal Canto MC; Barrett TA; Miller SD
Cell Immunol; 2000 Oct; 205(1):24-33. PubMed ID: 11078604
[TBL] [Abstract][Full Text] [Related]
28. Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis.
Gonnella PA; Waldner HP; Kodali D; Weiner HL
J Autoimmun; 2004 Nov; 23(3):193-200. PubMed ID: 15501390
[TBL] [Abstract][Full Text] [Related]
29. Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.
Anderson K; Fitzgerald M; Dupont M; Wang T; Paz N; Dorsch M; Healy A; Xu Y; Ocain T; Schopf L; Jaffee B; Picarella D
Autoimmunity; 2006 Sep; 39(6):469-78. PubMed ID: 17060026
[TBL] [Abstract][Full Text] [Related]
30. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
Morini M; Roccatagliata L; Dell'Eva R; Pedemonte E; Furlan R; Minghelli S; Giunti D; Pfeffer U; Marchese M; Noonan D; Mancardi G; Albini A; Uccelli A
J Neuroimmunol; 2004 Mar; 148(1-2):146-53. PubMed ID: 14975595
[TBL] [Abstract][Full Text] [Related]
31. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way.
Berghmans N; Dillen C; Heremans H
J Neuroimmunol; 2006 Jul; 176(1-2):63-75. PubMed ID: 16764944
[TBL] [Abstract][Full Text] [Related]
32. Antibody response in MOG(35-55) induced EAE.
Lalive PH; Molnarfi N; Benkhoucha M; Weber MS; Santiago-Raber ML
J Neuroimmunol; 2011 Dec; 240-241():28-33. PubMed ID: 21993076
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
34. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
De Paula ML; Rodrigues DH; Teixeira HC; Barsante MM; Souza MA; Ferreira AP
Int Immunopharmacol; 2008 Sep; 8(9):1291-7. PubMed ID: 18602076
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation.
Gutcher I; Urich E; Wolter K; Prinz M; Becher B
Nat Immunol; 2006 Sep; 7(9):946-53. PubMed ID: 16906165
[TBL] [Abstract][Full Text] [Related]
36. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
37. NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis.
Cross AH; Ramsbottom MJ; Lyons JA
J Neuroimmunol; 2006 Apr; 173(1-2):79-86. PubMed ID: 16448705
[TBL] [Abstract][Full Text] [Related]
38. [The study of changes on NKT cells of experimental autoimmune encephalomyelitis (EAE) mice].
Ouyang Q; Chen K; Wang X; Zhang CM; Guo J; Wei YY; Sun YJ; Xu ZW; Yang K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Oct; 25(10):894-6. PubMed ID: 19811735
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Hofstetter HH; Ibrahim SM; Koczan D; Kruse N; Weishaupt A; Toyka KV; Gold R
Cell Immunol; 2005 Oct; 237(2):123-30. PubMed ID: 16386239
[TBL] [Abstract][Full Text] [Related]
40. Deficient p75 low-affinity neurotrophin receptor expression exacerbates experimental allergic encephalomyelitis in C57/BL6 mice.
Copray S; Küst B; Emmer B; Lin MY; Liem R; Amor S; de Vries H; Floris S; Boddeke E
J Neuroimmunol; 2004 Mar; 148(1-2):41-53. PubMed ID: 14975585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
